Daan Gene is an in-vitro diagnostics company supplying disease-diagnosis products and planning labs running clinical analyses for hospitals and individuals.
Daan Gene, established as a provider of molecular diagnosis solutions, sells multiple product lines across the in-vitro diagnostics industry under its own brands: Daan Gene for molecular diagnosis, Darui Biology for chemiluminescence immunoassay analyzers, LBP for pathology, and Zhongshan Bio-Tech for point-of-care testing. GP Pharma Capital, a wholly owned subsidiary of Guangzhou Pharmaceutical Group, acquired control of Daan Gene.
Its molecular diagnosis solutions cover the full screening process, from sampling and nucleic acid extraction through PCR preparation and amplification to diagnostic reports. Daan Gene distributes these solutions internationally through subsidiaries and distributor partners, and its objectives include setting up laboratories to perform clinical analyses for hospitals and individuals.
